Published in J Clin Endocrinol Metab on March 01, 1995
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev (2008) 2.64
Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2011) 1.74
Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int (2008) 1.51
Detection, evaluation, and treatment of eating disorders the role of the primary care physician. J Gen Intern Med (2000) 1.37
Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab (2006) 1.27
Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr (2006) 1.25
Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab (2009) 1.22
Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab (2009) 1.18
Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry (2011) 1.17
Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone (2009) 1.15
Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int (2004) 1.08
Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab (2007) 1.03
The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism (2012) 1.01
Relation between bone turnover, oestradiol, and energy balance in women distance runners. Br J Sports Med (1998) 0.98
Medical complications occurring in adolescents with anorexia nervosa. West J Med (2000) 0.96
Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol (2014) 0.95
Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone (2009) 0.95
Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab (2014) 0.95
Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab (2008) 0.95
Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev (2009) 0.93
Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes (2011) 0.91
Endocrine dysregulation in anorexia nervosa update. J Clin Endocrinol Metab (2011) 0.90
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med (2006) 0.90
A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int (2005) 0.89
Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int (2005) 0.88
Anorexia nervosa and bone. J Endocrinol (2014) 0.87
Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab (2014) 0.86
Anorexia nervosa, obesity and bone metabolism. Pediatr Endocrinol Rev (2013) 0.86
Management of ischiopubic stress fracture in patients with anorexia nervosa and excessive compulsive exercising. BMJ Case Rep (2014) 0.84
A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm (Vienna) (2007) 0.84
Skeletal outcomes by peripheral quantitative computed tomography and dual-energy X-ray absorptiometry in adolescent girls with anorexia nervosa. Osteoporos Int (2016) 0.84
Body composition and skeletal health: too heavy? Too thin? Curr Osteoporos Rep (2012) 0.82
Endocrinology of anorexia nervosa in young people: recent insights. Curr Opin Endocrinol Diabetes Obes (2014) 0.82
Bone metabolism in anorexia nervosa. Curr Osteoporos Rep (2014) 0.82
Endocrine effects of anorexia nervosa. Endocrinol Metab Clin North Am (2013) 0.81
Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab (2007) 0.81
Management of anorexia and bulimia nervosa: An evidence-based review. Indian J Psychiatry (2010) 0.80
Bone metabolism in adolescents with anorexia nervosa. J Endocrinol Invest (2011) 0.80
Eighty-five per cent of what? Discrepancies in the weight cut-off for anorexia nervosa substantially affect the prevalence of underweight. Psychol Med (2008) 0.80
The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology (2011) 0.80
The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects. CNS Drugs (2016) 0.80
Anorexia nervosa. BMJ Clin Evid (2011) 0.79
Evidence of a link between resting energy expenditure and bone remodelling, glucose homeostasis and adipokine variations in adolescent girls with anorexia nervosa. Osteoporos Int (2015) 0.78
State of the art systematic review of bone disease in anorexia nervosa. Int J Eat Disord (2015) 0.78
Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res (2014) 0.78
A displaced femoral neck stress fracture in an amenorrheic adolescent female runner. Sports Health (2012) 0.78
Anorexia Nervosa and Its Associated Endocrinopathy in Young People. Horm Res Paediatr (2016) 0.77
Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities. Osteoporos Int (2012) 0.77
Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling. Osteoporos Int (2006) 0.77
Reproductive issues in anorexia nervosa. Expert Rev Obstet Gynecol (2011) 0.76
Anorexia nervosa. BMJ Clin Evid (2009) 0.76
The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol (2016) 0.75
Current perspectives on the etiology and manifestation of the "silent" component of the Female Athlete Triad. Int J Womens Health (2014) 0.75
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review. Nutrients (2016) 0.75
Anorexia nervosa and bone metabolism. Bone (2014) 0.75
Objective estimates of the probability of death from burn injuries. N Engl J Med (1998) 5.56
Carpal tunnel release. A prospective, randomized assessment of open and endoscopic methods. J Bone Joint Surg Am (1993) 5.04
Sample-size formula for the proportional-hazards regression model. Biometrics (1983) 5.00
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med (2001) 3.78
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol (1997) 2.84
A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer (1985) 2.82
Eating disorders. N Engl J Med (1999) 2.77
Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics (1982) 2.74
National patterns of physician activities related to obesity management. Arch Fam Med (2000) 2.54
A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med (1990) 2.48
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry (2000) 2.41
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
A 3-year-old boy's chronic diarrhea and unexplained death. J Am Acad Child Adolesc Psychiatry (1991) 2.19
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology (2003) 2.10
Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab (1994) 2.09
Osteoporosis in women with anorexia nervosa. N Engl J Med (1984) 1.99
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA (1991) 1.93
Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol (2000) 1.93
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.91
The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab (1999) 1.89
Properties of proportional-hazards score tests under misspecified regression models. Biometrics (1984) 1.84
Sensitivity of the Diagnostic Interview Schedule for Children, 2nd edition (DISC-2.1) for specific diagnoses of children and adolescents. J Am Acad Child Adolesc Psychiatry (1993) 1.83
Analysing survival in the presence of an auxiliary variable. Stat Med (1994) 1.75
Eating disorders in males: a report on 135 patients. Am J Psychiatry (1997) 1.70
Pregnancy complications and neonatal outcomes in women with eating disorders. Am J Psychiatry (2001) 1.62
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med (1993) 1.62
Eating disorders. N Engl J Med (1985) 1.62
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab (1989) 1.61
Osteopenia in men with a history of delayed puberty. N Engl J Med (1992) 1.59
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab (1998) 1.57
Combining mortality and longitudinal measures in clinical trials. Stat Med (1999) 1.56
Exposure to the mass media and weight concerns among girls. Pediatrics (1999) 1.54
Activity, inactivity, and obesity: racial, ethnic, and age differences among schoolgirls. Am J Public Health (1993) 1.53
HCC patients suffer less from geographic differences in organ availability. Am J Transplant (2013) 1.52
Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord (2000) 1.49
What predicts suicide attempts in women with eating disorders? Psychol Med (2004) 1.49
Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology (1989) 1.46
Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest (2001) 1.45
Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg (1988) 1.45
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
Resolved: the pass rate for the child and adolescent psychiatry board examination should be higher than it is at present. J Am Acad Child Adolesc Psychiatry (1991) 1.38
Design considerations for AIDS trials. N Engl J Med (1990) 1.38
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med (1996) 1.34
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab (1992) 1.34
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med (2000) 1.33
Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974-1984). Ann Surg (1986) 1.32
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg (1992) 1.28
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. Am J Clin Nutr (1997) 1.26
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis (2000) 1.22
Long-term outcome of children surviving massive burns. JAMA (2000) 1.20
Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer. Gynecol Oncol (1990) 1.14
The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med (1999) 1.12
Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab (2004) 1.09
Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1983) 1.07
Antidepressant use in eating disorders. Psychosomatics (1986) 1.07
Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med (1999) 1.06
Do fish oils prevent restenosis after coronary angioplasty? Circulation (1994) 1.05
Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab (2007) 1.03
Age and bone mass in premenopausal women. J Bone Miner Res (1989) 1.02
Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry (1995) 1.02
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. Biometrics (1998) 1.00
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer (1982) 1.00
Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am (1997) 1.00
Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab (1991) 0.99
A proportional hazards model for truncated AIDS data. Biometrics (1993) 0.98
Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg (1993) 0.98
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol (1987) 0.98
Frequency of bulimic behaviors and associated social maladjustment in female graduate students. J Psychiatr Res (1986) 0.98
Nonparametric estimation in a cure model with random cure times. Biometrics (2001) 0.96
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol (Oxf) (2001) 0.96
A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer. Cancer (1985) 0.96
Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J Clin Endocrinol Metab (1988) 0.96
Neuroleptic malignant syndrome: review of experience with children and adolescents. J Child Adolesc Psychopharmacol (1992) 0.95
Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab (1998) 0.94
A phase I study of ampligen in human immunodeficiency virus-infected subjects. J Infect Dis (1992) 0.93
Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci U S A (1994) 0.93
Pregnancy: outcome and impact on symptomatology in a cohort of eating-disordered women. Int J Eat Disord (2000) 0.92
The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab (1994) 0.92
Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab (1997) 0.92
Neurochemical abnormalities of anorexia nervosa and bulimia nervosa. Am J Psychiatry (1989) 0.92
Patient-generated dysphoria in house officers. J Med Educ (1984) 0.92
Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab (1988) 0.90
Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab (1992) 0.90
The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation (1999) 0.89
How should DSM-V classify eating disorder not otherwise specified (EDNOS) presentations in women with lifetime anorexia or bulimia nervosa? Psychol Med (2010) 0.89
Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol (1985) 0.89
Evolving trends in liver transplantation: an outcome and charge analysis. Transplantation (1999) 0.88
Sexual conflict and eating disorders in 27 males. Am J Psychiatry (1984) 0.87
Bulimia: the secretive syndrome. Psychosomatics (1982) 0.87
Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab (1998) 0.87
Anger attacks in eating disorders. Psychiatry Res (1995) 0.87
Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. AJR Am J Roentgenol (1998) 0.86
Combination therapy with zidovudine, didanosine and saquinavir. Antiviral Res (1996) 0.85